Next generation ALS drug silences inherited form of the disease in animal models

Researchers delayed signs of amyotrophic lateral sclerosis (ALS) in rodents by injecting them with a second-generation drug designed to silence the gene, superoxide dismutase 1 (SOD1). The results suggest the newer version of the drug may be effective at treating an inherited form of the disease caused by mutations in SOD1.

🕐 Top News in the Last Hour By Importance Score

#	Title	📊 i-Score
1	Scores killed in US strikes on Yemen fuel port of Ras Isa, Houthi officials say	🟢 82 / 100
2	What are communities across the country doing to save our damaged rivers?	🔴 75 / 100
3	What we know about Kilmar Abrego Garcia, the Maryland man mistakenly deported to El Salvador	🔴 75 / 100
4	Swedish boy, 15, is arrested for 'trying to hire hitmen to kill rival gang members' after he was sent away to Australia to get away from his criminal friends	🔴 75 / 100
5	Four killed after spring storms wreak havoc in the Alps	🔴 72 / 100
6	Idaho murders trial judge rules on Bryan Kohberger's autism defense and if roommate can say 'bushy eyebrows'	🔴 72 / 100
7	Horror as child, 7, dies after woman 'sends poisoned Easter egg to ex's new family'	🔴 65 / 100
8	The tale of Paul Revere’s Ride remains very much worth telling — 250 years later	🔵 55 / 100
9	Championship roundup: Solomon keeps Leeds top with victory at Oxford	🔵 45 / 100
10	Robin Goodfellow's racing tips: Best bets for Saturday, April 19	🔵 35 / 100

View More Top News ➡️